Abstract
Purpose
This study examined the association between medication adherence (MA) and health-related quality of life (HRQoL) among the adult type 2 diabetes mellitus at the primary care level.
Methods
In this cross-sectional study, the 8-item Morisky Medication Adherence Scale (MMAS) was the main independent variable and the World Health Organization Quality of Life-Brief the dependent variable. Besides socio-demographic data, diabetes-related distress (DRD) and depression (DS) were included as covariates. Independent association between the MMAS score and HRQoL was done using multiple linear regression.
Results
The participants’ response rate was 93.1 % (700/752). Majorities were female (52.8 %), Malay (52.9 %) and married (79.1 %). The mean (SD) for age and the MMAS score was 56.9 (10.18) and 5.6 (1.42), respectively. MMAS total score correlated significantly with all HRQoL domains: overall QoL (OQoL) (r = 0.17), physical QoL (r = 0.11), psychological QoL (r = 0.10), social relationship QoL (r = 0.15) and environmental QoL (EQoL) (r = 0.18). After adjustment for covariates (age, gender, ethnicity, religion, education, income, exercise, macrovascular complications, DRD and DS), MA had persistent effects on OQoL (B = 0.53, 95 % CI 0.012–1.048) and EQoL (B = 0.95, 95 % CI 0.235–1.667).
Conclusion
MA showed prevalent correlation and positive effects on the domains of HRQoL. Despite the small effects of MA on HRQoL, the sheer presence of the independent effects provides healthcare providers good reason for initiative and intervention to improve MA, which would improve quality of life.
Similar content being viewed by others
Abbreviations
- DDS:
-
The 17-item Diabetes Distress Scale
- DFP:
-
Diabetic foot problems
- DRD:
-
Diabetes-related distress
- DS:
-
Depression
- EQoL:
-
Environment quality of life
- HRQoL:
-
Health-related quality of life
- MA:
-
Medication adherence
- MacroCx:
-
Macrovascular complications
- MicroCx:
-
Microvascular complications
- MMAS:
-
The 8-item Morisky Medication Adherence Scale
- OQoL:
-
Overall quality of life
- PHQ:
-
The 9-item Patient Health Questionnaire
- PQoL:
-
Physical quality of life
- SRQoL:
-
Social relationships quality of life
- T2DM:
-
Type 2 diabetes mellitus
- WHOQOL-BREF:
-
The World Health Organization Quality of Life-Brief
- YQoL:
-
Psychological quality of life
References
Asche, C., LaFleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33, 74–109.
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.
Manan, M. M., Husin, A. R., Alkhoshaiban, A. S., Al-Worafi, Y. M., & Ming, L. C. (2014). Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. Journal of Clinical and Diagnostic Research, 8, JC05–JC09.
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42, 102–109.
Martinez, Y. V., Prado-Aguilar, C. A., Rascon-Pacheco, R. A., & Valdivia-Martinez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8, 164.
Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348–354.
Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90, 216–221.
Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.
Group, T.W. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28, 551–558.
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care, 28, 626–631.
El Achhab, Y., Nejjari, C., Chikri, M., & Lyoussi, B. (2008). Disease-specific health-related quality of life instruments among adults diabetic: A systematic review. Diabetes Research and Clinical Practice, 80, 171–184.
Fisher, L., Hessler, D. M., Polonsky, W. H., & Mullan, J. (2012). When is diabetes distress clinically meaningful?: Establishing cut points for the Diabetes Distress Scale. Diabetes Care, 35, 259–264.
Chew, B. H., Mukhtar, F., Mohd-Sidik, S., Paimin, F., Noor-Hasliza Hassan, N.-H., Jamaludin, N.-K. (2015). The 17-items Diabetes Distress Scale (DDS): Translation and validation of the Malay version. Malays Fam Physician (submitted).
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613.
Sherina, M. S., Arroll, B., & Goodyear-Smith, F. (2012). Criterion validity of the PHQ-9 (Malay version) in a primary care clinic in Malaysia. Medical Journal of Malaysia, 67, 309–315.
WHO Consultation. (1999. Report no. 99.2.). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization.
Ministry of Health, Malaysia. (2009). Management of type 2 diabetes mellitus. Putrajaya: Technology, Health Section, Assessment Division, Medical Development.
American Diabetes Association. (2015). Standards of medical care in diabetes—2015. Diabetes Care, 38, S1–S93.
Fisher, L., Mullan, J. T., Arean, P., Glasgow, R. E., Hessler, D., & Masharani, U. (2010). Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care, 33, 23–28.
van Bastelaar, K. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Tack, C. J., Bazelmans, E., Beekman, A. T., et al. (2010). Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabetic Medicine, 27, 798–803.
Ahmad, N. S., Ramli, A., Islahudin, F., & Paraidathathu, T. (2013). Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference Adherence, 7, 525–530.
(2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. In NICE clinical guideline 76. Manchester, UK.
Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., & Lindenmeyer, A. (2005). Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews (Online), CD003638–CD003638.
Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65, 314–322.
Non-Communicable Disease Section, Disease Control Division, Department of Public Health. National Diabetes Registry Report, Volume 1: 2009–2012 (2013).
Acknowledgments
This study received its funding from the Research University Grants Scheme 2 (RUGS/04-02-2105RU). I would like to record my acknowledgment to WHO and Dr. Al-Qazaz H.K. et al. for the use of WHOQOL-BREF and the MMAS-8 Malay version, respectively. I also like to acknowledge the Sepang and Petaling District Health Offices and officers for their support in this study and Director General of Health for his permission to publish this report. I thank Dr. Firdaus Mukhtar, Professor Sherina Mohd Sidik, Dr. Nor-Kasmawati Jamaludin and Dr. Fuziah Paimin for their input during the study planning and assistance in data collection. Lastly, I would like to thank all the clinic staffs for facilitating the data collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chew, BH. Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study. Qual Life Res 24, 2723–2731 (2015). https://doi.org/10.1007/s11136-015-1006-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-015-1006-7